Durect Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Biofrontera and BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | ||
Founding Date | Founding Date N/A | Founding Date 2012 | Founding Date 1948 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cupertino, US HQ | Locations Leverkusen, DE HQ | |
Employees | Employees 902% increase | Employees 91 | Employees 650 |
Valuation ($) | Valuation ($) 45.3 m | Valuation ($) 1.1 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods €2.2m (FY, 2025) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit €11.2m (FY, 2025) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($8.3m) (FY, 2024) | Net income (€6.9m) (FY, 2025) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Biofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company